TRANSVAC is a collaborative infrastructure project funded by the European Commission under HORIZON 2020 and coordinated by the European Vaccine Initiative (EVI). The project is a joint effort of leading European groups working in the field of vaccine development. It improves European research and training in the vaccine field, and implements a permanent research infrastructure for early vaccine development, to accelerate vaccine development and increase the sustainability of European Commission vaccine projects.
Seppic contributed to the TRANSVAC initiative in an adjuvant training session organized on March 25th in Geneva. Aude Puget Marketing manager Human Biologicals delivered a global overview of Water in oil adjuvants and their use in vaccines. Participants from all over Europe received some key points of understanding on history, mechanisms of action and how to handle these adjuvants in vaccine formulations.